Covered recipient · General Payments record
DEGACHE FUKIAU
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2024
$295.35
- Reported across 11 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $295.35 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $148.63 | 4 |
| Novo Nordisk AS | $87.79 | 4 |
| Lilly USA, LLC | $42.23 | 2 |
| Astellas Pharma US Inc | $16.70 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $295.35 | 11 |
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $16.70 | 07/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1139531832 | CMS |
| AstraZeneca Pharmaceuticals LP | $98.95 | 02/13/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105263337 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.94 | 07/16/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105250192 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.11 | 08/02/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105469495 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.63 | 08/20/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1104690760 | CMS |
| Lilly USA, LLC | $22.43 | 02/21/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135607643 | CMS |
| Lilly USA, LLC | $19.80 | 08/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135634220 | CMS |
| Novo Nordisk Inc | $16.69 | 07/19/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1100304425 | CMS |
| Novo Nordisk Inc | $21.45 | 07/24/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1100610980 | CMS |
| Novo Nordisk Inc | $21.75 | 08/01/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1100458470 | CMS |
| Novo Nordisk Inc | $27.90 | 08/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1100614775 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.